Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutionalized patients.

Kolbe F, Sitar DS, Papaioannou A, Campbell G.

Can J Clin Pharmacol. 2003 Fall;10(3):119-22.

PMID:
14506511
2.
3.

Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000.

Bowles SK, Lee W, Simor AE, Vearncombe M, Loeb M, Tamblyn S, Fearon M, Li Y, McGeer A; Oseltamivir Compassionate Use Program Group..

J Am Geriatr Soc. 2002 Apr;50(4):608-16.

PMID:
11982659
4.

Influenza outbreak in a long-term-care facility: considerations for pharmacy.

Bowles SK, Kennie N, Ruston L, Simor A, Louie M, Collins V.

Am J Health Syst Pharm. 1999 Nov 15;56(22):2303-7.

PMID:
10582821
5.

Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in the nursing home.

Degelau J, Somani S, Cooper SL, Irvine PW.

J Am Geriatr Soc. 1990 Apr;38(4):428-32.

PMID:
2329251
6.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
7.

Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.

Risebrough NA, Bowles SK, Simor AE, McGeer A, Oh PI.

J Am Geriatr Soc. 2005 Mar;53(3):444-51.

PMID:
15743287
8.

The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home.

Arden NH, Patriarca PA, Fasano MB, Lui KJ, Harmon MW, Kendal AP, Rimland D.

Arch Intern Med. 1988 Apr;148(4):865-8.

PMID:
3355306
9.

Experience with oseltamivir in the control of a nursing home influenza B outbreak.

Parker R, Loewen N, Skowronski D.

Can Commun Dis Rep. 2001 Mar 1;27(5):37-40. English, French.

10.

Emergence and transmission of amantadine-resistant influenza A in a nursing home.

Schilling M, Gravenstein S, Drinka P, Cox N, Krause P, Povinelli L, Shult P.

J Am Geriatr Soc. 2004 Dec;52(12):2069-73.

PMID:
15571544
11.

Treatment of an influenza A outbreak in a teaching nursing home. Effectiveness of a protocol for prevention and control.

Peters NL, Oboler S, Hair C, Laxson L, Kost J, Meiklejohn G.

J Am Geriatr Soc. 1989 Mar;37(3):210-8.

PMID:
2918190
12.

Comparison of pharmacokinetic and safety profiles of amantadine 50- and 100-mg daily doses in elderly nursing home residents.

Somani SK, Degelau J, Cooper SL, Guay DR, Ehresman D, Zaske D.

Pharmacotherapy. 1991;11(6):460-6.

PMID:
1771145
13.

Adverse reactions to amantadine prophylaxis of influenza in a retirement home.

Stange KC, Little DW, Blatnik B.

J Am Geriatr Soc. 1991 Jul;39(7):700-5.

PMID:
2061537
15.

Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols.

Drinka PJ, Gravenstein S, Schilling M, Krause P, Miller BA, Shult P.

Arch Intern Med. 1998 Oct 26;158(19):2155-9.

PMID:
9801184
16.

Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

Mast EE, Harmon MW, Gravenstein S, Wu SP, Arden NH, Circo R, Tyszka G, Kendal AP, Davis JP.

Am J Epidemiol. 1991 Nov 1;134(9):988-97.

PMID:
1951297
17.

Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine.

Libow LS, Neufeld RR, Olson E, Breuer B, Starer P.

J Am Geriatr Soc. 1996 Oct;44(10):1153-7.

PMID:
8855992
18.

Amantadine-resistant influenza A in a nursing facility.

Degelau J, Somani SK, Cooper SL, Guay DR, Crossley KB.

Arch Intern Med. 1992 Feb;152(2):390-2.

PMID:
1739371
19.

Control of influenza A outbreaks in nursing homes: amantadine as an adjunct to vaccine--Washington, 1989-90.

Centers for Disease Control (CDC)..

MMWR Morb Mortal Wkly Rep. 1991 Dec 13;40(49):841-4.

PMID:
1961174
20.

Use of antivirals in influenza in the elderly: prophylaxis and therapy.

Nicholson KG.

Gerontology. 1996;42(5):280-9. Review.

PMID:
8940651

Supplemental Content

Support Center